Piperacillin and Tazobactam
- Product NDC
- 60505-0687
- 11-digit product format
- 605050687
- Labeler code
- 60505
- Product ID
- 60505-0687_1afc82ad-fa69-4822-b312-08efbffb9996
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PIPERACILLIN and TAZOBACTAM
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Apotex Corporation
- Application
- ANDA065386
- Marketing category
- ANDA
- Marketing start
- 2009-09-21
- Marketing end
- 2019-09-30
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 3 g/15mL; g/15mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 60505-0687 | D | Discontinued by firm | 2026-09-14 | ||
| excluded package | package | 60505-0687 | 60505-0687-4 | D | Discontinued by firm | 2026-09-14 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 60505-0687-4 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 60505-0687-4 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 60505-0687-4 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 60505-0687-4 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 60505-0687-4 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 60505-0687-4 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 60505-0687-4 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 60505-0687-4 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 60505-0687-4 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 60505-0687-4 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 60505-0687-4 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 60505-0687-4 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065386-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | ||
| A065386-002 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | ||
| A065386-003 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065386-002 | PIPERACILLIN AND TAZOBACTAM | EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A065386-003 | PIPERACILLIN AND TAZOBACTAM | EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A065386-001 | PIPERACILLIN AND TAZOBACTAM | EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL | INJECTABLE / INJECTION | 2009-09-15 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-09-15 20:21 UTC | 2019-09 | A065386-001 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A065386-002 | AP | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A065386-003 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A065386-001 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A065386-002 | AP | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A065386-003 | AP | 1 | ea99ee380514… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0687-1 | EA - Each | 60505-0687 | 1bfd9699-505e-46d6-9f9c-aec4d704f0d8 | 1 | 2015-11-12 |
| 60505-0687-4 | EA - Each | 60505-0687 | ff46ef12-a54e-4496-ab83-f4d1545bd67c | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PIPERACILLIN SODIUM | ACTIVE INGREDIENT | M98T69Q7HP | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [APOTEX CORPORATION] | 8 | |
| TAZOBACTAM SODIUM | ACTIVE INGREDIENT | UXA545ABTT | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [APOTEX CORPORATION] | 8 | |
| PIPERACILLIN ANHYDROUS | ACTIVE MOIETY | 9I628532GX | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [APOTEX CORPORATION] | 8 | |
| TAZOBACTAM | ACTIVE MOIETY | SE10G96M8W | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, FOR SOLUTION [APOTEX CORPORATION] | 8 |